الدليل الوطني للأدوية المسجّلة في لبنان
تحتوي هذه الفقرة على المعلومات الخاصة بالمستحضرات الصيدلانية المسجّلة في وزارة الصحة العامة وهي المرجع الرسمي الوحيد لقاعدة بيانات الأدوية المسموح لتسويقها في لبنان
يمكنكم البحث أدناه عن المعلومات الرسمية للأدوية المسجّلة بالاضافة الى نسبة الدعم
الأدوية التي ليها رمز ينتهي ب "945/" تخضع للقرار رقم 1/945 تاريخ 3/10/2022
| ATC | Name | B/G | Ingredients | Dosage | Form | Price |
|---|---|---|---|---|---|---|
| L01DB01 | CAELYX | B | Doxorubicin HCl pegylated liposomes - 20mg/10ml | 20mg/10ml | Injectable concentrated solution | 34821487.44284 |
| L01CX01 | YONDELIS | B | Trabectedin - 1mg | 1mg | Injectable powder for solution | 126536515.21875 |
| L01CE02 | IRINOGEN | G | Irinotecan HCl - 100mg | 100mg | Injectable solution | 5239641.9075 |
| L01CE02 | IRINOGEN | G | Irinotecan HCl - 100mg | 100mg | Injectable solution | 5239641.9075 |
| L01CE02 | IRINOTECAN GP PHARM | G | Irinotecan HCl trihydrate - 100mg/5ml | 100mg/5ml | Injectable concentrated solution | 5239641.9075 |
| L01CE02 | IRINOTECAN HYDROCHLORIDE | G | Irinotecan HCl - 100mg/5ml | 100mg/5ml | Injectable concentrate for solution | 2085643.56 |
| L01CE02 | IRINOTECAN THYMOORGAN | G | Irinotecan HCl - 100mg/5ml | 100mg/5ml | Injectable concentrated solution | 6111795.69 |
| L01CE02 | IRNOCAM 100 | G | Irinotecan HCl - 100mg/5ml | 100mg/5ml | Injectable solution | 7320946.6865 |
| L01CE02 | IRINOTECAN THYMOORGAN | G | Irinotecan HCl - 40mg/2ml | 40mg/2ml | Injectable concentrated solution | 2123271.15 |
| L01CE02 | IRNOCAM 40 | G | Irinotecan HCl - 40mg/2ml | 40mg/2ml | Injectable solution | 908693.5 |
| L01CE01 | HYCAMTIN IV | B | Topotecan HCl - 4mg | 4mg | Injectable lyophilised powder for solution | 52580031.189 |
| L01CE01 | HYCAMTIN IV | B | Topotecan HCl - 4mg | 4mg | Injectable lyophilised powder for solution | 52580031.189 |
| L01CE01 | TOPOTU | G | Topotecan HCl - 4mg/4ml | 4mg/4ml | Injectable concentrated solution | 7253795.6778 |
| L01CD04 | CABAZITAXEL EVER PHARMA | G | Cabazitaxel - 60mg/6ml | 10mg/ml | Injectable concentrate for solution | |
| L01CD04 | JEVTANA INJECTION | B | Cabazitaxel - 60mg/1.5ml | 60mg/1.5ml | Injectable dry powder for solution+diluent | 75619930.806 |
| L01CD04 | JEVTANA INJECTION | B | Cabazitaxel - 60mg/1.5ml | 60mg/1.5ml | Injectable dry powder for solution+diluent | 75619930.806 |
Download the new version of the MOPH app
for the latest updates on Coronavirus.
The new version of the MOPH APP will provide you with all the reliable information on COVID-19 with ongoing update of the confirmed cases and data. If you are showing any symptoms, the “Symptoms Checker” will be your self-help guide to assess them.
